Sleep disorders interactions with obesity and type 2 diabetes
| Autor: | Sofia Y. Buharova, Oxana V. Bazhenova, Tatyana O. Brodovskaya, Genia G. Babykina, Irina F. Grishina, Olga V. Nikolaenko, Valeria E. Beresneva, Egor A. Kovin |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Pediatrics
medicine.medical_specialty obesity Physiology Endocrinology Diabetes and Metabolism insomnia 030209 endocrinology & metabolism Type 2 diabetes QD415-436 Biochemistry 03 medical and health sciences 0302 clinical medicine Endocrinology Internal Medicine Medicine QP1-981 Nutrition and Dietetics business.industry Public Health Environmental and Occupational Health apnea medicine.disease Sleep in non-human animals Obesity sleep duration sleep disorders type 2 diabetes business 030217 neurology & neurosurgery |
| Zdroj: | Ожирение и метаболизм, Vol 16, Iss 4, Pp 25-30 (2019) |
| ISSN: | 2306-5524 2071-8713 |
| Popis: | Obesity and type II diabetes are 21st century pandemia. These metаbolic disorders are in the focus of attention of various specialties: cardiologists, endocrinologists, nutritionists, therapists, and others. The high incidence of obesity and type II diabetes cardiovascular complications, such as myocardial infarction, stroke, chronic heart failure, dementia, determine the call of risk factors search. Modifiable factors may include sleep disturbances. Recent studies have revealed a connection between changes in sleep duration and metabolic disorders. However, to date, the mechanisms underlying this association have not been established. The aim of the review is to summarize existing epidemiological and experimental observations, as well as an analysis of possible pathophysiological mechanisms linking sleep duration with obesity and type II diabetes. The article considers current data suggesting a bi-directional association of sleep disorders with obesity and diabetes. Sleep disturbances are significant determinant of developing metabolic disorders. Sleep duration correction as one of therapeutic targets for cardiovascular complications of obesity and type II diabetes prevention. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|